Breast Cancer Clinical Trial

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Summary

This non-therapeutic trial is for women who have received results of genetic testing for BRCA1/2 mutations. The trial compares decision support tools designed to facilitate informed decision making regarding risk management following testing to usual care. The researchers will test separate decision support tools for women who receive positive test results and women who receive negative/inconclusive test results. Among women who receive a positive test result, an interactive decision support intervention will be compared to a print intervention. Among women who receive an inconclusive result, an interactive intervention will be compared to usual care.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Undergo BRCA1/2 genetic counseling and testing at one of four study sites
Receive positive or uninformative test results
English speaking

Exclusion Criteria:

Newly diagnosed breast cancer patients who have not yet initiated definitive breast cancer treatment
Previous bilateral mastectomy

Study is for people with:

Breast Cancer

Estimated Enrollment:

369

Study ID:

NCT02133703

Recruitment Status:

Completed

Sponsor:

Georgetown University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Georgetown University Medical Center/Lombardi Comprehensive Cancer Center
Washington District of Columbia, 20007, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

369

Study ID:

NCT02133703

Recruitment Status:

Completed

Sponsor:


Georgetown University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.